|Videos|July 27, 2022

Dr. Alexis Rompré-Brodeur on germline testing in renal cell carcinoma

“We wanted to revisit the current main indications for germline testing,” says Alexis Rompré-Brodeur, MD.

Alexis Rompré-Brodeur, MD, a urologic oncologist at McGill University discusses germline testing in patients with renal cell carcinoma. Rompré-Brodeur presented the study, “Germline testing in renal cell carcinoma: can enrichment features help predict germline alterations?” at the 2022 AUA Annual Meeting.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.


Latest CME